Virtual Dialogue: Addressing breast cancer - how civil society’s advocacy drives change

In Salzburg, the effects of the prevention program were scientifically investigated.The result: No improvement in early diagnosis compared to previously - without mammography project.

The First Breast Cancer Forum – National Congress with International Participation will be held on April 11th and 12th in the Congress Hall of the Hotel “Kragujevac”, organized by doctors and professors of the University Clinical Center Kragujevac and the Faculty of Medical Sciences of the University of Kragujevac, with the support of the Ministry of Health of the Republic of Serbia. The two-day professional gathering will feature plenary lectur…

The female breast has been, throughout history, a symbol loaded with meanings: life, beauty, sexualization. However, for many women around the world, this symbol is enveloped in painful and complex realities. From breast amputations for breast cancer to impossible aesthetic demands, to cultural practices such as breast ironing and the rise of mastectomy in adolescents by gender ideology, these experiences reflect a constant struggle for health, …

Virtual Dialogue: Addressing breast cancer - how civil society’s advocacy drives change

giuga 2025-04-07 - 14:55 Virtual Dialogue: Addressing breast cancer - how civil society’s advocacy drives change 29 April 2025, 14:00-15:00 Central European Summer Time (click here to convert timezone)  Date and time Tuesday, 29 April 2025 - 14:00 - Tuesday, 29 April 2025 - 15:00 Join this Virtual Dialogue to gain practical knowledge and advocacy strategies for improving early detection of breast cancer and access to treatment in your country,…

Not even one in two women aged 45 and over takes the study, a study questions the effectiveness of the programme.

The impact of the Austrian early detection program calls into question a study from Salzburg. Despite the introduction of a structured screening, there would be little improvement in the discovery of breast cancer in early stages, according to researchers around the oncologist Richard Greil.